Skip to main content
Betty Hamilton, MD, Oncology, Cleveland, OH

BettyKyHamiltonMD

Oncology • Cleveland, OH

Hematologic Oncology

Assistant Professor, Medicine, Case Western Reserve U SOM

Join to view full profile

Dr. Hamilton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hamilton's full profile

Already have an account?

  • Office

    9500 Euclid Ave
    Taussig Cancer Institute CA60
    Cleveland, OH 44195
    Phone+1 216-445-7580

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2010 - 2013
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2006 - 2009
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2006

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2010 - 2026
  • PA State Medical License
    PA State Medical License 2006 - 2010
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell Transplantation  
    Deepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature

Abstracts/Posters

  • Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia
    Betty K. Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
    Betty K. Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Long-Term Experience with Large Granular Lymphocytic Leukemia Evolving after Solid Organ and Hematopoietic Stem Cell Transplantation
    Betty K. Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Clinical Management of Myeloid Malignancies: The Coming of Age of Targeted Therapies 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Ch... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Post-Transplant Cyclophosphamide Increases Risk for Early Cardiac Events
    Post-Transplant Cyclophosphamide Increases Risk for Early Cardiac EventsAugust 16th, 2021
  • Post-Transplant Cyclophosphamide Increases Risk of Cardiac Events
    Post-Transplant Cyclophosphamide Increases Risk of Cardiac EventsJune 15th, 2021
  • Risk Factors for Mortality in Day +100 Survivors of Allogeneic HCT
    Risk Factors for Mortality in Day +100 Survivors of Allogeneic HCTJune 12th, 2018
  • Join now to see all

Dr. Betty Hamilton, Dr. Betty Hamilton, MD, Dr. B Hamilton, Dr. Betty Ky Hamilton